Where is this lab located? Does it matter? Countless electrons have been spilled in the promotion of the biotech and life science industries in and around New York City. Indeed,…
According to Wikipedia, Management by Wandering Around (MBWA) is ...refers to a style of business management which involves managers wandering around, in an unstructured manner, through the workplace(s), at random,…
#BIO2017 is days away. What can we expect? Crowded Partnering - By our unofficial count, the number of companies registered for One-on-One Partnering exceeds the number from San…
An Acceptance Rate is simply the percentage of meeting requests which are accepted at a given conference. At Lacerta Bio, we have been tracking Acceptance Rates for conferences since…
NSAIDs are an $11-12+ billion market, yet the problems with these drugs continue to make headlines. The most recent study examined data from nearly 450,000 patients, and concluded (our…
The following commentary is from Mr. Tom Brya, Managing Director at Titenare GXL. Titenare is an international consultancy providing integrated, knowledge-based services and solutions to pharma companies internationally. For further…
A recent post by Robert Wessman of Alvogen pointed out that some companies are abandoning their efforts in the biosimilars markets. Amgen, for instance, recently decided to postpone…
We just returned from a brief trip to England, where we met with a client, plus a few friends and colleagues. Over several meetings and meals, three issues consistently came…
Last week, the US Centers for Disease Control published a rather alarming report on drug overdose deaths in the US. Here are a few items which we found…
BIO starts in June, right? Wrong. Perhaps BIO starts in late April, when partnering opens? Sorry. Wrong again. BIO started the moment you decided to…